Identificador persistente para citar o vincular este elemento: https://accedacris.ulpgc.es/handle/10553/44346
Campo DC Valoridioma
dc.contributor.authorSamaranch, Lluísen_US
dc.contributor.authorLorenzo-Betancor, Oswaldoen_US
dc.contributor.authorArbelo González, José Matíasen_US
dc.contributor.authorFerrer, Isidreen_US
dc.contributor.authorLorenzo, Elenaen_US
dc.contributor.authorIrigoyen, Jaioneen_US
dc.contributor.authorPastor, Maria A.en_US
dc.contributor.authorMarrero, Carmenen_US
dc.contributor.authorIsla, Concepciónen_US
dc.contributor.authorHerrera-Henriquez, Joannaen_US
dc.contributor.authorPastor, Pauen_US
dc.date.accessioned2018-11-21T22:15:18Z-
dc.date.available2018-11-21T22:15:18Z-
dc.date.issued2010en_US
dc.identifier.issn0006-8950en_US
dc.identifier.urihttps://accedacris.ulpgc.es/handle/10553/44346-
dc.description.abstractPhosphatase and tensin homolog-induced putative kinase 1 gene mutations have been associated with autosomal recessive early-onset Parkinson’s disease. To date, no neuropathological reports have been published from patients with Parkinson’s disease with both phosphatase and tensin homolog-induced putative kinase 1 gene copies mutated. We analysed the coding region of phosphatase and tensin homolog-induced putative kinase 1 gene in a large Spanish family with six members with parkinsonism. The phenotype was characterized by an early-onset (mean: 31.6, standard deviation: 9.6 years, range: 14–45 years), slowly progressive levodopa-responsive parkinsonism, initial gait impairment and psychiatric symptoms. We identified two segregating pathogenic phosphatase and tensin homolog-induced putative kinase 1 mutations that were either in homozygous or heterozygous compound state in all affected family members. We found an exon 7 deletion (g.16089_16383del293; c.1252_1488del) and a novel + 1U1-dependent 5′ splice-site mutation in exon 7 (g.16378G > A; c.1488 + 1G > A). Leukocyte-derived messenger RNA analysis showed that both mutations caused exon 7 skipping and c.1488 + 1G > A also lead to an in-frame transcript with a 33 base-pair deletion (p.L485_R497del) resulting from activation of a 5′ cryptic exon 7 splice site. Single photon emission computed tomography quantification of striatal dopamine transporter binding (123I-Ioflupane) revealed a posterior–anterior gradient similar to that of idiopathic Parkinson’s disease, but there was no correlation between striatal reduced uptake and disease duration. Post-mortem neuropathological examination of an early-onset Parkinson’s disease carrier of two heterozygous compound phosphatase and tensin homolog-induced putative kinase 1 mutations showed neuronal loss in the substantia nigra pars compacta, Lewy bodies and aberrant neurites in the reticular nuclei of the brainstem, substantia nigra pars compacta and Meynert nucleus, but the locus ceruleus and the amygdala were spared. This is the first neuropathological report of the brain from an early-onset phosphatase and tensin homolog-induced putative kinase 1-linked parkinsonism showing that mutated phosphatase and tensin homolog-induced putative kinase 1 protein induces Lewy body pathology. Unbalanced preservation of the locus ceruleus may well play a role in the slow evolution of motor symptoms and, probably, in the psychiatric symptoms often encountered in Parkinson’s disease associated with phosphatase and tensin homolog-induced putative kinase 1 mutation.en_US
dc.languageengen_US
dc.publisher0006-8950-
dc.relation.ispartofBrain (Print)en_US
dc.sourceBrain [ISSN 0006-8950], v. 133, p. 1128-1142en_US
dc.subject320507 Neurologíaen_US
dc.subject.otherParkinson’s diseaseen_US
dc.subject.otherSplicing mutationen_US
dc.subject.otherLewy bodyen_US
dc.subject.otherNeuropathologyen_US
dc.subject.otherSPECTen_US
dc.titlePINK1-linked parkinsonism is associated with Lewy body pathologyen_US
dc.typeinfo:eu-repo/semantics/articlees
dc.typeArticlees
dc.identifier.doi10.1093/brain/awq051en_US
dc.identifier.scopus2-s2.0-77950855127-
dc.contributor.authorscopusid57140437300-
dc.contributor.authorscopusid36025528700-
dc.contributor.authorscopusid26655226900-
dc.contributor.authorscopusid36042305900-
dc.contributor.authorscopusid25723450300-
dc.contributor.authorscopusid35069490700-
dc.contributor.authorscopusid56962720000-
dc.contributor.authorscopusid57060774700-
dc.contributor.authorscopusid16241216700-
dc.contributor.authorscopusid35791862500-
dc.contributor.authorscopusid56513542800-
dc.description.lastpage1142-
dc.description.firstpage1128-
dc.relation.volume133-
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.identifier.ulpgces
dc.description.jcr9,232
dc.description.jcrqQ1
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.fullNameArbelo González, José Matías-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

214
actualizado el 30-mar-2025

Citas de WEB OF SCIENCETM
Citations

195
actualizado el 30-mar-2025

Visitas

59
actualizado el 31-dic-2023

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.